Effects of aspirin for primary prevention of ASCVDs in DM type2 patients
Completed
- Conditions
- Cardiovascular Event in Type 2 diabetes patientsCardiovascular disease, Primary prevention, Aspirin, Type 2 diabetes
- Registration Number
- TCTR20240328011
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 682
Inclusion Criteria
1. Type 2 DM patients that were diagnosed and treatment at Bangmulnak Hospital.
Exclusion Criteria
1. Patients with former history of cardiovascular diseases.
2. History of aspirin allergy.
3. Patients use other antiplatelet or anticoagulant.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incident of CVD events 3 years after last enrolment Review of electrical medical records
- Secondary Outcome Measures
Name Time Method /A N/A N/A